Quality of Care — Role Development, Implementation and Evaluation of Nurse Practitioners
Citation(s)
Hajat C, Stein E The global burden of multiple chronic conditions: A narrative review. Prev Med Rep. 2018 Oct 19;12:284-293. doi: 10.1016/j.pmedr.2018.10.008. eCollection 2018 Dec.
ICN, I C. o. N. (2020). Guidelines on advanced practice nursing. In: International Council of Nurses Geneva.
Jarrett LA, Emmett M Utilizing trauma nurse practitioners to decrease length of stay. J Trauma Nurs. 2009 Apr-Jun;16(2):68-72. doi: 10.1097/JTN.0b013e3181ac91c1.
Jennings N, Clifford S, Fox AR, O'Connell J, Gardner G The impact of nurse practitioner services on cost, quality of care, satisfaction and waiting times in the emergency department: a systematic review. Int J Nurs Stud. 2015 Jan;52(1):421-35. doi: 10.1016/j.ijnurstu.2014.07.006. Epub 2014 Jul 24.
Schober M Global emergence of nurse practitioner/advanced practice nursing roles. J Am Assoc Nurse Pract. 2018 Apr;30(4):182-184. doi: 10.1097/JXX.0000000000000029. No abstract available.
WHO (2018). European health report 2018: More than numbers-evidence for all: World Health Organization. Regional Office for Europe.
Role Development, Implementation and Evaluation of Nurse Practitioners in a Belgian University Hospital.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.